These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9511979)

  • 1. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients.
    Christodoulou J; Danks DM; Sarkar B; Baerlocher KE; Casey R; Horn N; Tümer Z; Clarke JT
    Am J Med Genet; 1998 Mar; 76(2):154-64. PubMed ID: 9511979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-histidine therapy for Menkes disease.
    Sarkar B; Lingertat-Walsh K; Clarke JT
    J Pediatr; 1993 Nov; 123(5):828-30. PubMed ID: 8229500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menkes' disease: long-term treatment with copper and D-penicillamine.
    Nadal D; Baerlocher K
    Eur J Pediatr; 1988 Aug; 147(6):621-5. PubMed ID: 3181204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper-histidine treatment of Menkes disease.
    Garnica A; Chan WY; Rennert O
    J Pediatr; 1994 Aug; 125(2):336-8. PubMed ID: 8093166
    [No Abstract]   [Full Text] [Related]  

  • 5. [Manufacturing and stability of copper-histidine solution for treatment of Menkes' Kinky Hair Syndrome].
    Hoppe-Tichy T; Nguyen TH; Hentze BW; Lorke M
    Pharmazie; 2005 Mar; 60(3):205-7. PubMed ID: 15801674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menkes' kinky-hair disease: radiologic findings in a patient treated with copper histidinate.
    Waslen TA; Houston CS; Tchang S
    Can Assoc Radiol J; 1995 Apr; 46(2):114-7. PubMed ID: 7704673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment.
    Tümer Z; Petris M; Zhu S; Mercer J; Bukrinski J; Bilz S; Baerlocher K; Horn N; Møller LB
    Clin Genet; 2017 Nov; 92(5):548-553. PubMed ID: 28657131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menkes disease after copper histidine replacement therapy: case report.
    George DH; Casey RE
    Pediatr Dev Pathol; 2001; 4(3):281-8. PubMed ID: 11370266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease.
    Kroepfl T; Mair E; Deutsch J; Brunner-Krainz M; Paschke E; Plecko B
    J Inherit Metab Dis; 2006 Aug; 29(4):593. PubMed ID: 16786254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT manifestations of Menkes' kinky hair syndrome (trichopoliodystrophy).
    Farrelly C; Stringer DA; Daneman A; Fitz CR; Sass-Kortsak A
    J Can Assoc Radiol; 1984 Dec; 35(4):406-8. PubMed ID: 6526854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of copper-histidine therapy on brain metabolism in a patient with Menkes disease: a proton magnetic resonance spectroscopic study.
    Munakata M; Sakamoto O; Kitamura T; Ishitobi M; Yokoyama H; Haginoya K; Togashi N; Tamura H; Higano S; Takahashi S; Ohura T; Kobayashi Y; Onuma A; Iinuma K
    Brain Dev; 2005 Jun; 27(4):297-300. PubMed ID: 15862194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Menkes disease variant with occipital horns: delineation of natural history and clinical phenotype.
    Proud VK; Mussell HG; Kaler SG; Young DW; Percy AK
    Am J Med Genet; 1996 Oct; 65(1):44-51. PubMed ID: 8914740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early copper histidine therapy in classic Menkes disease.
    Sarkar B
    Ann Neurol; 1997 Jan; 41(1):134-6. PubMed ID: 9005880
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Menkes disease with parenteral copper histidine.
    Kirodian BG; Gogtay NJ; Udani VP; Kshirsagar NA
    Indian Pediatr; 2002 Feb; 39(2):183-5. PubMed ID: 11867850
    [No Abstract]   [Full Text] [Related]  

  • 15. Long surviving classical Menkes disease treated with weekly intravenous copper therapy.
    Ogata R; Chong PF; Maeda K; Imagi T; Nakamura R; Kawamura N; Kira R
    J Trace Elem Med Biol; 2019 Jul; 54():172-174. PubMed ID: 31109608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease.
    Kreuder J; Otten A; Fuder H; Tümer Z; Tønnesen T; Horn N; Dralle D
    Eur J Pediatr; 1993 Oct; 152(10):828-32. PubMed ID: 8223785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early copper therapy in classic Menkes disease patients with a novel splicing mutation.
    Kaler SG; Buist NR; Holmes CS; Goldstein DS; Miller RC; Gahl WA
    Ann Neurol; 1995 Dec; 38(6):921-8. PubMed ID: 8526465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menkes' disease: report of a case and determination of eumelanin and pheomelanin in hypopigmented hair.
    Tomita Y; Kondo Y; Ito S; Hara M; Yoshimura T; Igarashi H; Tagami H
    Dermatology; 1992; 185(1):66-8. PubMed ID: 1638075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome.
    Ogawa E; Kodama H
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):102-4. PubMed ID: 22575542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function in patients with Menkes disease.
    Ozawa H; Kodama H; Kawaguchi H; Mochizuki T; Kobayashi M; Igarashi T
    Eur J Pediatr; 2003 Jan; 162(1):51-2. PubMed ID: 12607531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.